Lumoe Skin1 Skin Remedy Tablet, Chewable
FDA Label NDC 81425-007

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Applied Bioenergetics, Llc for the product Lumoe Skin1 Skin Remedy (NDC 81425-007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, otc - active ingredient, otc - purpose, indications & usage, warnings, otc - keep out of reach of children, dosage & administration, other safety information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Other

→ Otc - Active Ingredient

→ Otc - Purpose

→ Indications & Usage

→ Warnings

→ Otc - Keep Out Of Reach Of Children

→ Dosage & Administration

→ Other Safety Information

→ Inactive Ingredient

→ Otc - Questions

→ Lumoe Skin-1 Remedy* Localized Itchy, Irritated Skin* Labeling

Other

Drug Facts

*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED
MEDICAL EVIDENCE. NOT FDA EVALUATED.

Otc - Active Ingredient

Active Ingredients
Kali muriaticum 12c
Prunus spinosa 30c
Silicea 30c
Sarsaparilla 30c

Otc - Purpose

Purpose*
Kali muriaticum .......................................... Itchy, erythema (redness), blemish
Prunus spinosa ............................................................. Headaches, sacral pain
Silicea .................................................................................. Itchy sensitive skin
Sarsaparilla ...................................................................... Localized crusty skin

Indications & Usage

Uses*Temporarily Relieves Minor and Occasional Symptoms:
• itchy • redness • blemish • headaches • sacral pain • sensitive crusty skin

Warnings

Warnings
• Ask a doctor before use in children under 12 years of age.
• Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
• If pregnant or breastfeeding, consult your health professional before use.

Otc - Keep Out Of Reach Of Children

• Keep out of reach of children.

Dosage & Administration

Directions
• For adults and children 12 and over: At the onset of symptoms 3 tablets, every 30
minutes for 3 hours. Then 3 tablets every hour up to 6 times a day for 3 days until
symptoms are relieved or as recommended by your healthcare professional.
• For children under 12: Ask a doctor.